PDB15- COST-EFFECTIVENESS ANALYSIS OF GRAFTSKIN (APLIGRAF) AND BECAPLERMIN (REGRANEX) IN DIABETIC NEUROPATHIC FOOT ULCERS

May 1, 2003, 00:00 AM
10.1016/S1098-3015(10)64180-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64180-0/fulltext
Section Title :
Section Order : 380
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64180-0&doi=10.1016/S1098-3015(10)64180-0
HEOR Topics :
Tags :
Regions :